Pelgraz is the only BVB G-CSF available in both a pre-filled injector and a pre-filled syringe. This choice of injection device is designed to meet the specific needs of healthcare professionals and patients. Pelgraz also has the longest product stability of any BVB G-CSF at a maximum single period of up to 15 days.
Pelgraz joins Accords other High-Tech medicine Sondelbay (Teriparatide) as a HSE designated Best Value Medicine.
Accord, part of the Intas group, manufactures this medicine in its own facility, where they now have the second highest number of biosimilars in phase III to approval in the world.
Please refer to the Summary of Product Characteristics (SPC) for further information. The SPC is available from hpra.ie and from accord-healthcare.ie.
Highlighted Articles
